AstraZeneca PLC
SWB:ZEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
SWB:ZEG
|
UK |
|
E
|
Edwards Lifesciences Corp
SWB:EWL
|
US |
|
Enbridge Inc
F:EN30
|
CA |
|
Compass Minerals International Inc
NYSE:CMP
|
US |
|
Byline Bancorp Inc
NYSE:BY
|
US |
|
DraftKings Inc
F:IK1
|
US |
Wall St Price Targets
ZEG Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for ZEG is 189.49 EUR with a low forecast of 131.35 EUR and a high forecast of 247.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZEG's stock price target?
Price Target
189.49
EUR
According to Wall Street analysts, the average 1-year price target for ZEG is 189.49 EUR with a low forecast of 131.35 EUR and a high forecast of 247.73 EUR.
What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 13%.
What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 13%.
